Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Lipidor Ab

LIPI
Current price
0.13 SEK +0.0025 SEK (+1.98%)
Last closed 0.13 SEK
Company lipidor.se
ISIN SE0012558617
Sector Healthcare
Industry Drug Manufacturers - General
Exchange Stockholm Exchange
Capitalization 100 192 664 SEK
Yield for 12 month -88.10 %
1Y
3Y
5Y
10Y
15Y
LIPI
21.11.2021 - 28.11.2021

Lipidor AB (publ), a pharmaceutical development company, engages in the development of drugs for the treatment of psoriasis, acne vulgaris, bacterial skin infections, and atopic dermatitis. The company develops AKP-01, which is in Phase III for the treatment of psoriasis; and preclinical stage products, such as AKP-02 for psoriasis, AKP-03 for bacterial skin diseases, and AKP-07 for atopic dermatitis. It offers active pharmaceutical ingredients used in products for various therapeutic applications, such as anti-psoriasic, antimicrobial, anti-inflammatory, antifungal, local anesthetics, non-steroidal anti-inflammatory, anti-acne, wound healing, anti-eczema, and anti-migraine. The company also develops a range of spray products for animal skin care in dogs, cats, and horses; and consumer health care products for applications, including antibacterial, antiseptic, moisturizing emollient, disinfectant, and acne and wart treatment. It has a collaboration agreement with Cannassure Therapeutics Ltd. for the development of topical medicinal cannabis products for the treatment of skin inflammations and psoriatic lesions. The company was incorporated in 2009 and is based in Danderyd, Sweden. Address: Svärdvägen 13, Danderyd, Sweden, 182 33

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

10.17 SEK

P/E ratio

Dividend Yield

Current Year

+77 482 SEK

Last Year

+44 704 SEK

Current Quarter

Last Quarter

+17 884 SEK

Current Year

-15 360 368 SEK

Last Year

-41 440 122 SEK

Current Quarter

-58 612 SEK

Last Quarter

-365 562 SEK

Key Figures LIPI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -14 597 472 SEK
Operating Margin TTM -16350.54 %
PE Ratio
Return On Assets TTM -54.18 %
PEG Ratio
Return On Equity TTM -178.09 %
Wall Street Target Price 10.17 SEK
Revenue TTM 92 383 SEK
Book Value 0.021 SEK
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 21375 %
Dividend Yield
Gross Profit TTM -29 532 679 SEK
Earnings per share -0.16 SEK
Diluted Eps TTM -0.16 SEK
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics LIPI

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History LIPI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation LIPI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 954.0781
Price Sales TTM 1106.4044
Enterprise Value EBITDA 0.0028
Price Book MRQ 6.3157

Financials LIPI

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators LIPI

For 52 weeks

0.04 SEK 1.29 SEK
50 Day MA 0.064 SEK
Shares Short Prior Month
200 Day MA 0.29 SEK
Short Ratio
Shares Short
Short Percent